Kay Townsend

1.5k total citations
22 papers, 1.2k citations indexed

About

Kay Townsend is a scholar working on Genetics, Molecular Biology and Virology. According to data from OpenAlex, Kay Townsend has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 7 papers in Molecular Biology and 7 papers in Virology. Recurrent topics in Kay Townsend's work include Virus-based gene therapy research (9 papers), HIV Research and Treatment (7 papers) and Immunotherapy and Immune Responses (4 papers). Kay Townsend is often cited by papers focused on Virus-based gene therapy research (9 papers), HIV Research and Treatment (7 papers) and Immunotherapy and Immune Responses (4 papers). Kay Townsend collaborates with scholars based in United States, United Kingdom and France. Kay Townsend's co-authors include Douglas J. Jolly, Thomas W. Dubensky, Sybille L. Sauter, Andrew L. Glasebrook, Bruce E. Torbett, W Roeder, Gary S. Firestein, Joanne T. Hom, Casey T. Weaver and Nicholas J. DePolo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Journal of Virology.

In The Last Decade

Kay Townsend

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kay Townsend United States 16 502 465 452 298 230 22 1.2k
A. M. Abai United States 9 512 1.0× 240 0.5× 468 1.0× 247 0.8× 153 0.7× 11 1.0k
Theresa A. Banks United States 19 1.2k 2.4× 217 0.5× 292 0.6× 581 1.9× 238 1.0× 25 1.8k
Urs Hoffmann Rohrer Switzerland 9 993 2.0× 127 0.3× 343 0.8× 324 1.1× 214 0.9× 9 1.5k
H L Robinson United States 14 451 0.9× 271 0.6× 491 1.1× 329 1.1× 232 1.0× 22 1.2k
C. de Taisne France 11 580 1.2× 253 0.5× 885 2.0× 271 0.9× 192 0.8× 16 1.7k
Hanne Gahéry‐Ségard France 16 484 1.0× 542 1.2× 530 1.2× 253 0.8× 280 1.2× 18 1.2k
Paul Zhou United States 22 571 1.1× 176 0.4× 435 1.0× 457 1.5× 264 1.1× 70 1.5k
T J Braciale United States 14 997 2.0× 182 0.4× 398 0.9× 490 1.6× 154 0.7× 17 1.5k
John M. Lubinski United States 24 520 1.0× 273 0.6× 255 0.6× 1.0k 3.4× 134 0.6× 35 1.4k
Marcio O. Lasaro United States 21 588 1.2× 601 1.3× 518 1.1× 349 1.2× 345 1.5× 31 1.4k

Countries citing papers authored by Kay Townsend

Since Specialization
Citations

This map shows the geographic impact of Kay Townsend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay Townsend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay Townsend more than expected).

Fields of papers citing papers by Kay Townsend

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay Townsend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay Townsend. The network helps show where Kay Townsend may publish in the future.

Co-authorship network of co-authors of Kay Townsend

This figure shows the co-authorship network connecting the top 25 collaborators of Kay Townsend. A scholar is included among the top collaborators of Kay Townsend based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay Townsend. Kay Townsend is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Townsend, Kay, et al.. (2019). Functional assessment of complement proteins C1q, C2, C3 and C5. Clinica Chimica Acta. 493. S39–S39. 1 indexed citations
2.
Chen, Yong, Christopher J. Ott, Kay Townsend, et al.. (2008). Cholesterol supplementation during production increases the infectivity of retroviral and lentiviral vectors pseudotyped with the vesicular stomatitis virus glycoprotein (VSV-G). Biochemical Engineering Journal. 44(2-3). 199–207. 21 indexed citations
3.
Stein, Colleen S., Yubin Kang, Sybille L. Sauter, et al.. (2001). In Vivo Treatment of Hemophilia A and Mucopolysaccharidosis Type VII Using Nonprimate Lentiviral Vectors. Molecular Therapy. 3(6). 850–856. 74 indexed citations
4.
Sheridan, Philip L., Mordechai Bodner, Nicholas J. DePolo, et al.. (2000). Generation of Retroviral Packaging and Producer Cell Lines for Large-Scale Vector Production and Clinical Application: Improved Safety and High Titer. Molecular Therapy. 2(3). 262–275. 49 indexed citations
5.
DePolo, Nicholas J., Philip L. Sheridan, Kay Townsend, et al.. (2000). VSV-G Pseudotyped Lentiviral Vector Particles Produced in Human Cells Are Inactivated by Human Serum. Molecular Therapy. 2(3). 218–222. 163 indexed citations
6.
Polo, John M., Barbara Belli, David A. Driver, et al.. (1999). Stable alphavirus packaging cell lines for Sindbis virus- and Semliki Forest virus-derived vectors. Proceedings of the National Academy of Sciences. 96(8). 4598–4603. 109 indexed citations
7.
Sällberg, Matti, Janice Hughes, Ali Javadian, et al.. (1998). Genetic Immunization of Chimpanzees Chronically Infected with the Hepatitis B Virus, Using a Recombinant Retroviral Vector Encoding the Hepatitis B Virus Core Antigen. Human Gene Therapy. 9(12). 1719–1729. 48 indexed citations
8.
Hariharan, Mangala J., David A. Driver, Kay Townsend, et al.. (1998). DNA Immunization against Herpes Simplex Virus: Enhanced Efficacy Using a Sindbis Virus-Based Vector. Journal of Virology. 72(2). 950–958. 145 indexed citations
9.
Schwedler, Uta von, et al.. (1997). Retroviral-Mediated Expression of FIV Envelope/Rev Induces CD8+ CTL Responses in Mice. Intervirology. 40(4). 271–276. 1 indexed citations
10.
McCormack, James E., Darlene Martineau, Nicholas J. DePolo, et al.. (1997). Anti-Vector Immunoglobulin Induced by Retroviral Vectors. Human Gene Therapy. 8(10). 1263–1273. 20 indexed citations
11.
Townsend, Kay, Matti Sällberg, Theresa A. Banks, et al.. (1997). Characterization of CD8+ cytotoxic T-lymphocyte responses after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B virus core and e antigens. Journal of Virology. 71(5). 3365–3374. 46 indexed citations
12.
Sällberg, Matti, Kay Townsend, Theresa A. Banks, et al.. (1997). Characterization of humoral and CD4+ cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigens. Journal of Virology. 71(7). 5295–5303. 22 indexed citations
13.
14.
15.
Jolly, Douglas J., Sunil Chada, Kay Townsend, et al.. (1992). CTL Cross Reactivity Between HIV Strains. AIDS Research and Human Retroviruses. 8(8). 1369–1371. 2 indexed citations
16.
Warner, John F., et al.. (1991). Induction of HIV-Specific CTL and Antibody Responses in Mice Using Retroviral Vector-Transduced Cells. AIDS Research and Human Retroviruses. 7(8). 645–655. 36 indexed citations
17.
Firestein, Gary S., W Roeder, Kay Townsend, et al.. (1989). A new murine CD4+ T cell subset with an unrestricted cytokine profile.. The Journal of Immunology. 143(2). 518–525. 313 indexed citations
18.
Kanagawa, Osami, et al.. (1987). Identification of a novel T cell surface disulfide-bonded dimer distinct from the alpha/beta antigen receptor.. The Journal of Immunology. 138(3). 815–824. 59 indexed citations
19.
Gemmell, C. G., et al.. (1982). Biological effects of the interaction of staphylococcal alpha-toxin with human serum. Infection and Immunity. 38(3). 981–985. 13 indexed citations
20.
McLean, R H, et al.. (1975). The effect of anticomplementary substances on properdin in normal and C2-deficient sera.. PubMed. 19(3). 435–44. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. M. Abai Breakdown of academic impact, for papers by Theresa A. Banks Breakdown of academic impact, for papers by Urs Hoffmann Rohrer Breakdown of academic impact, for papers by H L Robinson Breakdown of academic impact, for papers by C. de Taisne Breakdown of academic impact, for papers by Hanne Gahéry‐Ségard Breakdown of academic impact, for papers by Paul Zhou Breakdown of academic impact, for papers by T J Braciale Breakdown of academic impact, for papers by John M. Lubinski Breakdown of academic impact, for papers by Marcio O. Lasaro
Rankless by CCL
2026